1.CROSS-SECTIONAL STUDY OF PREGNANT FEMALE PELVIS
Yiling MA ; Junben JIANG ; Jingru HAN
Acta Anatomica Sinica 1955;0(03):-
Two cases of full term pregnant female cadavers (fetal head entered pelvis) were used for preparing a serial abdomimal cross-sections. Seven sections were selected in which the fetal major viscera were presented. The position, shape,relationship and the dimensions of the uterus,fetus,appendages of the fetus as well as the corresponding relation between showing sections of the fetal major viscera and mother's vertebras were observed. The results of the observation article would have some practical significance to diagnosis of the pregnant image.
2.Study on neuron apoptosis in the patients with temporal lobe epilepsy characterized by hippocampus sclerosis
Huojun HU ; Yiling HUANG ; Lei WANG ; Xiongwei WANG ; Jinman GUO ; Jinyang MA
Chinese Journal of Postgraduates of Medicine 2014;37(32):10-12
Objective To explore the role and expression of cell apoptosis regulatory genes in patients with temporal lobe epilepsy characterized by hippocampus sclerosis.Methods The experimental specimens were obtained from 15 patients with temporal lobe epilepsy (epilepsy group) and 6 control samples (control group) were obtained from temporal lobe excision of brain trauma decompression,investigated neuron apoptosis by HE stain,TdT-mediated dUTP-biotin nick end labeling (TUNEL) method,and determined the expression of bcl-2,bax and caspase-3 by immunohistochemistry.Results The evidence of neuron apoptosis was not found by HE stain in both control group and epilepsy group.Positive cells was not found in control group,but was obviously observed in epilepsy group by TUNEL staining [(4.39 ± 2.04) numbers/100].Unlike that in normal adult brain,bcl-2 immunoreactivity was obviously observed in some neurons in epilepsy group[(6.72 ± 3.36) numbers/100] (P < 0.01).Compared with control group,bax protein in epilepsy group was mild expression (P > 0.05).Two cases in control group were detected the expression of caspase-3 protein,and caspase-3 significantly increased in epilepsy group [(1.07 ± 0.43),(9.54 ± 3.68) numbers/100] (P < 0.01).Conclusions Neuron apoptosis is an important cause of hippocampal sclerosis of human epilepsy.bcl-2 and caspase-3 may play an important role in this process.
3.Cholecystokinin octapeptide inhibits the in vitro expression of CD14 in rat pulmonary interstitial macrophages induced by lipopolysaccharide.
Shujin LI ; Bin CONG ; Yunli YAN ; Yuxia YAO ; Chunling MA ; Yiling LING
Chinese Medical Journal 2002;115(2):276-279
OBJECTIVETo study the effect of cholecystokinin octapeptide (CCK-8) on lipopolysaccharide (LPS)-stimulated pulmonary interstitial macrophages (PIM) in vitro.
METHODSPIM were isolated and cultured in the presence or absence of LPS, CCK-8, proglumide (the antagonist of CCK receptors) and vehicle. The expression of membrane CD14 (mCD14) protein was assayed by flow cytometry and soluble CD14 (sCD14) in the supernatant was analyzed semi-quantitatively by Western blot. TNF-alpha in the supernatant was detected with ELISA.
RESULTSCCK-8, at concentrations of 10(-7) mol/L and 10(-6) mol/L, significantly inhibited the expression of mCD14. Release of sCD14 and TNF-alpha in the supernatant was up-regulated by LPS (1 microg/ml) but reduced by CCK-8. The effect of CCK-8 was inhibited by proglumide.
CONCLUSIONCCK-8 negatively modulated several functions of LPS-stimulated PIM through CCK receptors. This may be one of the mechanisms for CCK-8 to alleviate inflammation in lung tissue during endotoxemia.
Animals ; Cells, Cultured ; Culture Media, Conditioned ; chemistry ; Female ; Lipopolysaccharide Receptors ; biosynthesis ; Lipopolysaccharides ; pharmacology ; Macrophages, Alveolar ; cytology ; drug effects ; metabolism ; Rats ; Rats, Sprague-Dawley ; Sincalide ; pharmacology ; Specific Pathogen-Free Organisms ; Tumor Necrosis Factor-alpha ; drug effects ; secretion
4.Application of hemostatic silk shielding on ulcers induced by endoscopic submucosal dissection
Zhong CHEN ; Yiling CAI ; Ming MA ; Zhongzheng HAN ; Qin ZHANG ; Junyao WANG ; Qinglin TANG ; Huayu ZHANG ; Mingqing ZHANG
China Journal of Endoscopy 2017;23(5):28-33
Objective To investigate the clinical value of hemostatic silk in prevention of wound bleeding and wound healing after endoscopic submucosal dissection (ESD). Methods Experiment group: animal model was made by rabbit underwent ESD simulation in its' stomach and laying hemostatic silk on its' wound;control group: animal model was made by pig underwent ESD simulation in its' colon without any healing management. All the ulcers sites were endoscopically and pathologically examined to evaluate the hemorrhage and healing of the wound on 3 days, 1 week, 2 weeks and 4 weeks after the procedure. Results The blood loss in experiment group was significantly lower than that in control group. The wounds of all the experimental pigs underwent colon ESD successfully covered with hemostatic silk postoperatively. Endoscopic pathological examination shown better healing procedure in experiment group. No procedure-related adverse event occurred in both groups. Conclusions Hemostatic silk has potential application value in healing the wound after ESD demonstrated by animal experiment.
5.Investigation of depression status of hospitalized pregnant women in labor
Yiling YANG ; Yue MA ; Cheng JI ; Xiaochun SUN ; Yemin WANG ; Changgui KOU
Journal of Jilin University(Medicine Edition) 2017;43(5):1053-1058
Objective:To learn the depression status of the hospitalized pregnant women in labor and its related influencing factors,and to provide the theoretical basis for exploring depression intervention of the pregnant women in labor.Methods:Self-Rating Depression Scale was used for investigating the depression status of 203 hospitalized pregnant women in labor who were in hospital from November 2014 to May 2015,and the impacts of demographic characteristics,maternal history and physical condition and health care on depression status of hospitalized pregnant women in labor before pregnancy and during pregnancy were analyzed using Logistic regression.Results:Fifty-three people with depressive tendencies were detected among pregnant women in labor,and the positive rate was 26.1%.The differences in positive rates of depression tendency of the pregnant women between less than 30 years,30-39 years and 40 years and above had no statistical significance (P>0.05).Univariate Logistic analysis showed that the differences of occupation,overweight or obesity,low-dose folic acid supplements before pregnancy were statistically significant (P<0.01).Multivariate Logistic regression analysis showed that risk factor for pregnant women was overweight or obesity pre-pregnancy,and the risk was 2.335 times to non-overweight or non-obesity pregnancy women (OR=2.335,95%CI:1.101-4.954,P<0.05).Conclusion:The pregnant women have the depression tendency,especially the pregnant women with high body mass index before pregnancy.The knowledge of psychological health education should be provided for them.
6.Practice and reflection on ethical review of clinical access and application of new medical technology
Yiling CHANG ; Niu ZHANG ; Lili MA ; Zhaqing XIE
Chinese Journal of Medical Science Research Management 2022;35(2):86-90
Objective:Taking into account of the current situation that domestic laws and regulations of medical technology ethics review are not perfect, we put forward practical suggestions on ethical review supervision of the clinical application of new medical technologies from the perspective of standardization.Methods:Referring to the relevant laws, regulations and specific implementation guidelines of ethical review of clinical research, combined with the practical experience of the ethics committee of the host Hospital, this paper systematically summarizes the concept and characteristics and existing problems of new clinical applied medical technology, optimizes the working steps of technology access and ethical review, and establishes an ethical continuing review model.Results:A series of measurements are proposed, which including formulate the access process, improve the management system, optimize ethical review methods, etc. At the same time, pay more attention to the annual continuing review, adverse event report review, suspension/termination of approved research, closure report review, as well as site visit to improve the initiative and efficiency of ethical review. At last, it ensures the continuing of ethical review.Conclusions:It is very important to regulate new medical technology project entry and ethical review supervision in the practice. On one hand, it can effectively make up for the possible shortcomings of current laws and regulations and promote the introduction of new regulatory requirement. On the other hand, it can effectively reduce the medical technology risks and build good medical quality management, improve the system to better safeguard people′s health rights and interests.
7.Germacrone reguates proliferation, migration and chemoresistance of thyroid cancer BCPAP cells through FOXO3-FOXM1 axis
WANG Hongtao1 ; MA Zheng2 ; SHAN Sixin3 ; ZHU Kunliang2 ; YUAN Liuyun2
Chinese Journal of Cancer Biotherapy 2024;31(9):871-877
[摘 要] 目的:探究吉马酮通过叉头盒蛋白O3(FOXO3)-FOX亚类M1转录因子(FOXM1)信号通路调控人甲状腺癌细胞BCPAP和多柔比星(DOX)耐药BCPAP细胞(BCPAP/DOX)的增殖、迁移和化疗耐药。方法:常规培养BCPAP细胞,用BCPAP细胞构建BCPAP/DOX细胞,用MTT法检测不同浓度吉马酮对BCPAP和BCPAP/DOX细胞增殖的影响。将BCPAP和BCPAP/DOX细胞分为Ctrl组(空白对照)、sh-NC组(转染sh-NC质粒)、低浓度吉马酮组(0.10 mmol/L)、高浓度吉马酮组(0.15 mmol/L)、高浓度吉马酮(0.15 mmol/L) + sh-FOXO3组(转染sh-FOXO3质粒),用转染试剂将sh-NC质粒和sh-FOXO3质粒转至相应的BCPAP和BCPAP/DOX细胞中。用CCK-8法、划痕愈合实验和WB法分别检测各组细胞的增殖、迁移能力,以及FOXO3、FOXM1、BAX、MMP-9和多药耐药-1(MDR-1)蛋白的表达。结果:在BCPAP和BCPAP/DOX细胞中成功地敲减了FOXO3的表达,低浓度和高浓度吉马酮均可显著抑制BCPAP和BCPAP/DOX细胞的增殖、迁移能力,降低细胞中FOMX1、MMP-9或MDR-1(BCPAP/DOX细胞)蛋白的表达,提升FOXO3和BAX蛋白的表达(均P < 0.05),与低浓度比较,高浓度吉马酮的作用更为显著(均P < 0.05),敲减FOXO3后可部分逆转吉马酮对这两种细胞的作用(均P < 0.05)。结论:吉马酮可能通过FOXO3/FOXM1信号通路调控BCPAP和BCPAP/DOX细胞的增殖和迁移能力,降低BCPAP/DOX细胞化疗耐药性。
8.Risk factors and sonographic findings associated with the type of placenta accreta spectrum disorders
Huijing ZHANG ; Ruochong DOU ; Li LIN ; Qianyun WANG ; Beier HUANG ; Xianlan ZHAO ; Dunjin CHEN ; Yiling DING ; Hongjuan DING ; Shihong CUI ; Weishe ZHANG ; Hong XIN ; Weirong GU ; Yali HU ; Guifeng DING ; Hongbo QI ; Ling FAN ; Yuyan MA ; Junli LU ; Yue YANG ; Li LIN ; Xiucui LUO ; Xiaohong ZHANG ; Shangrong FAN ; Huixia YANG
Chinese Journal of Obstetrics and Gynecology 2019;54(1):27-32
Objective To evaluate the risk factors and sonographic findings of pregnancies complicated by placenta increta or placenta percreta. Methods Totally, 2219 cases were retrospectively analyzed from 20 tertiary hospitals in China from January 2011 to December 2015. The data were collected based on the original case records. All cases were divided into two groups, the placenta increta (PI) group (79.1%, 1755/2219) and the placenta percreta (PP) group (20.9%, 464/2219), according to the degree of placental implantation. The risk factors and sonographic findings of placenta increta or percreta were analyzed by uni-factor and logistic regression statistic methods. Results The risk factors associated with the degree of placental implantation were age, gravida, previous abortion or miscarriage, previous cesarean sections, and placenta previa (all P<0.05), especially, previous cesarean sections (χ2=157.961) and placenta previa (χ2=91.759). Sonographic findings could be used to predict the degree of placental invasion especially the boundaries between placenta and uterine serosa, the boundary between placenta and myometrium, the disruption of the placental-uterine wall interface and loss of the normal retroplacental hypoechoic zone(all P<0.01). Conclusions Previous cesarean sections and placenta previa are the main independent risk factors associated with the degree of placenta implantation. Ultrasound could be used to make a prenatal suggestive diagnosis of placenta accreta spectrum disorders.
9.Umeclidinium bromide and vilanterol trifenatate in the treatment of COPD :an overview of systematic review and meta-analysis
Ying LAN ; Min XU ; Yiling LU ; Qing MA ; Qin HE
China Pharmacy 2022;33(1):96-103
OBJECTIVE To re-eval uate the systematic review and meta-an alysis of umeclidinium bromide and vilanterol trifenatate(UMEC/VIL)in the treatment of chronic obstructive pulmonary disease (COPD),so as to provide evidence-based basis for the treatment of COPD. METHODS Retrieved from PubMed (Medline),the Cochrane library ,Embase,CNKI,CBM,VIP and Wanfang database ,etc.,the systematic review and meta-analysis of UMEC/VIL in the treatment of COPD were collected from the inception to Apr. 2021. Two reviewers independently screened the literatures and extracted the data. AMSTAR 2 scale,PRISMA statement,and GRADE evaluation system were used to evaluate the methodological quality of the included studies ,the quality of reports and the grade of outcome indexes. The efficacy and safety of UMEC/VIL in the treatment of COPD were reported. RESULTS Six systematic reviews were finally included. The results of AMSTAR 2 scale showed that 1 study was of high quality , 2 were of medium quality and 3 were of low quality. The score of PRISMA statement was between 21.5 and 27,and the quality of the report was relatively perfect. The results of GRADE evaluation showed that more than 60% of the 134 outcome indicators were of medium to high quality of evidence. Comparison of effectiveness and safety showed that UMEC/VIL was superior to placebo , unilateral bronchodilator and salmeterol fluticasone in improving forced expiratory volume in one second (FEV1)trough,FEV1 peak and forced vital capacity (FVC). In the improvement of transition dyspnea index (TDI),SGRQ and SOBDA scores ,UMEC/ VIL was better than placebo ,unilateral bronchodilator and fluticasone propionate/salme terol. The adverse reaction rate ,acute exacerbation rate ,mortality rate ,withdrawal rate ,pneumonia rate and other negative indicators of UMEC/VIL were not inferior to placebo,unilateral bronchodilator and fluticasone propionate/salme terol. CONCLUSIONS Compared with placebo and unilateral bronchodilator,UMEC/VIL can significantly improve lung function ,symptoms and quality of life ,and has non-inferior effect for negative indicators. Compared with β2 adrenoceptor agonists combined with glucocorticoid ,UMEC/VIL can improve lung function of COPD patients ,but they are similar in other aspects.
10.Genome-wide identification of SUN gene family in Fragaria vesca and stresses-response analysis.
Yao YU ; Ziyao WANG ; Yiling XU ; Bojun MA ; Xifeng CHEN
Chinese Journal of Biotechnology 2023;39(2):724-740
SUN gene is a group of key genes regulating plant growth and development. Here, SUN gene families of strawberry were identified from the genome of the diploid Fragaria vesca, and their physicochemical properties, genes structure, evolution and genes expression were also analyzed. Our results showed that there were thirty-one FvSUN genes in F. vesca and the FvSUNs encoded proteins were classified into seven groups, and the members in the same group showed high similarity in gene structures and conservative motifs. The electronic subcellular localization of FvSUNs was mainly in the nucleus. Collinearity analysis showed that the members of FvSUN gene family were mainly expanded by segmental duplication in F. vesca, and Arabidopsis and F. vesca shared twenty-three pairs of orthologous SUN genes. According to the expression pattern in different tissues shown by the transcriptome data of F. vesca, the FvSUNs gene can be divided into three types: (1) expressed in nearly all tissues, (2) hardly expressed in any tissues, and (3) expressed in special tissues. The gene expression pattern of FvSUNs was further verified by quantitative real-time polymerase chain reaction (qRT-PCR). Additionally, the seedlings of F. vesca were treated by different abiotic stresses, and the expression level of 31 FvSUNs genes were assayed by qRT-PCR. The expression of most of the tested genes was induced by cold, high salt or drought stress. Our studies may facilitate revealing the biological function and molecular mechanism of SUN genes in strawberry.
Fragaria/metabolism*
;
Genes, Plant
;
Stress, Physiological/genetics*
;
Arabidopsis/genetics*
;
Plant Development
;
Gene Expression Regulation, Plant
;
Plant Proteins/metabolism*